LivaNova (LIVN) Share-based Compensation Growth (1y) (2017 - 2026)
LivaNova (LIVN) Share-based Compensation Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 9.69% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 37.62% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 12.16% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 12.94% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 59.09% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -30.44% |
| 10 | LivaNova | 4.40 Bn | 3.86 Bn | 243.75 Mn | 6.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.26% |
| Dec 31, 2025 | -88.42% |
| Sep 30, 2025 | -102.99% |
| Jun 30, 2025 | -147.59% |
| Mar 31, 2025 | -23.89% |
| Dec 31, 2024 | -76.33% |
| Sep 30, 2024 | 641.68% |
| Jun 30, 2024 | 92.28% |
| Mar 31, 2024 | 548.45% |
| Dec 31, 2023 | 138.35% |
| Sep 30, 2023 | -89.24% |
| Jun 30, 2023 | -62.95% |
| Mar 31, 2023 | -84.62% |
| Dec 31, 2022 | 23.29% |
| Sep 30, 2022 | -3.55% |
| Jun 30, 2022 | 16.06% |
| Mar 31, 2022 | 7.55% |
| Dec 31, 2021 | 147.03% |
| Sep 30, 2021 | 42.39% |
| Jun 30, 2021 | -0.75% |